On September 24, 2025, OneMedNet announced a strategic partnership with MedCase, a global network of over 15,000 healthcare professionals that provides medical data annotation services. The collaboration positions OneMedNet to offer regulatory‑grade, de‑identified real‑world data across imaging and EHR to MedCase’s clients, creating a new recurring revenue stream.
The partnership taps into the $1.5 billion healthcare data annotation market, projected to grow to $2.8 billion by 2030. By combining OneMedNet’s iRWD platform with MedCase’s annotation expertise, the two companies can deliver high‑margin, specialized datasets that are difficult for generalist data players to replicate.
CEO Aaron Green stated that the alliance “positions OneMedNet at the center of the healthcare data value chain” and that the combined offering will “unlock new growth channels that directly strengthen our long‑term revenue trajectory.” The deal is expected to accelerate OneMedNet’s expansion beyond RWD into a complementary, recurring revenue model.
This strategic shift is significant because it diversifies OneMedNet’s revenue base, reduces reliance on its core iRWD sales, and leverages a rapidly expanding market segment. The partnership also enhances the company’s competitive moat by integrating annotation services with its proprietary AI‑driven de‑identification platform, potentially driving higher customer adoption and retention.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.